Jorkasky Joins Tengion's Board While Gavin Departs
Tengion said Monday that Diane Jorkasky, M.D., has joined its board, while Brenda Gavin, D.V.M., is stepping down. Jorkasky recently joined Endo Pharmaceuticals as a SVP, Clinical Development and Chief Medical Officer. Gavin is a managing partner at Quaker BioVentures, which was an early VC investor in Tengion. East Norriton, Pa.-based Tengion is a clincal-stage biotech that develops neo-organs and neo-tissues from a patient's own cells.
15 August 2011•3 mins read
